References
- Nolly H, Carbini LA, Scicli G, Carretero OA, Scicli AG. A local kallikrein-kinin system is present in rat hearts. Hypertension. 1994; 6: 919–23
- Linz W, Wiemer G, Scholkens BA. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies. Diabetes. 1996; 45: S51–8
- Campbell DJ. The renin-angiotensin and the kallikrein-kinin systems. Int J Biochem Cell Biol. 2003; 35: 784–91
- Bugge E, Ytrehus K. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol. 1996; 28: 2333–41
- Wittstein IS, Kass DA, Pak PH, Maughan WL, Fetics B, Hare JM. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001; 38: 429–35
- Arvola L, Hassaf D, Melnikov AL, Helgesen KG, Ytrehus K. Adenosine induces prolonged anti-beta-adrenergic effects in guinea-pig papillary muscle. Acta Physiol Scand. 2002; 175: 11–7
- MacGowan GA, Evans C, Hu TC, Debrah D, Mullet S, Chen HH, et al. Troponin I protein kinase C phosphorylation sites and ventricular function. Cardiovasc Res. 2004; 63: 245–55
- Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem. 2003; 278: 35135–44
- Li Y, Sato T. Dual signaling via protein kinase C and phosphatidylinositol 3'-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts. J Mol Cell Cardiol. 2001; 33: 2047–53
- Perlini S, Khoury EP, Norton GR, Chung ES, Fenton RA, Dobson JG, Jr, et al. Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. Circ Res. 1998; 83: 761–71
- Brodde OE, Bruck H, Leineweber K, Seyfarth T. Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol. 2001; 96: 528–38
- Xiang Y, Kobilka BK. Myocyte adrenoceptor signaling pathways. Science 2003; 300: 1530–32
- Marceau F, Regoli D. Bradykinin receptor ligands: Therapeutic perspectives. Nat Rev Drug Discov. 2004; 3: 845–52
- Cooper M, Ytrehus K. Cell survival signalling in heart derived myofibroblasts induced by preconditioning and bradykinin: The role of p38 MAP kinase. Mol Cell Biochem. 2004; 259: 83–90
- Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol. 2004; 37: 449–71
- Goldspink PH, Montgomery DE, Walker LA, Urboniene D, McKinney RD, Geenen DL, et al. Protein kinase C epsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res. 2004; 95: 424–32
- Keef KD, Hume JR, Zhong J. Regulation of cardiac and smooth muscle Ca(2 + ) channels (Ca(V)1.2a,b) by protein kinases. Am J Physiol. 2001; 281: C1743–56
- Yue Y, Qu Y, Boutjdir M. Beta- and alpha-adrenergic cross-signaling for L-type Ca current is impaired in transgenic mice with constitutive activation of epsilonPKC. Biochem Biophys Res Commun. 2004; 314: 749–54
- Sundset R, Bertelsen G, Ytrehus K. Role of the Na+-H+ exchanger (NHE1) in heart muscle function during transient acidosis. A study in papillary muscles from rat and guinea pig hearts. Can J Physiol Pharmacol. 2003; 81: 937–43
- Munakata K, Dominic JA, Surawicz B. Variable effects of isoproterenol on action potential duration in guinea-pig papillary muscle. Differences between nonsteady and steady state; role of extracellular calcium concentration. J Pharmacol Exp Ther. 1982; 221: 806–14
- Gouin L, Cardinal R, Adam A, Drapeau G, Nadeau R. Kinin-induced prolongation of action-potential duration in right ventricular muscle from rat: Involvement of B1 and B2 receptors. J Cardiovasc Pharmacol. 1996; 28: 337–43